Zhiguo Wang - Yew Bio Chairman
| YEWBDelisted Stock | USD 0.0002 0.00 0.00% |
Chairman
Mr. Zhiguo Wang is Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Secretary of Yew BioPharm Group, Inc. He was the President and a director of YBP since the company was incorporated in November 2007, and was the Secretary of YBP since January 2010. Mr. Wang founded the company in 1996 and has served as Chairman of the Board and General Manager of HDS since its inception. Since August 2007, Mr. Wang has served as executive director of the China National Forest Industry Association. In January 2007, he was elected to the first board of directors by the Heilongjiang Province Pharmaceutical Professional Association. In August 2007, he was elected Executive Director of the China National Forest Industry Association. In December 2010, Mr. Wang was elected vice chairman of the Heilongjiang Province Forestry Industry Association. Mr. Wang is also involved in the management of other businesses, including Yew Pharmaceutical, Kairun and ZTC. Mr. Wang graduated from Northeast Forestry University, located in Harbin, for both his undergraduate and graduate degrees. since 2013.
| Age | 49 |
| Tenure | 11 years |
| Phone | 626 401 9588 |
| Web | https://www.yewbiopharm.com |
Yew Bio Management Efficiency
The company has return on total asset (ROA) of 0.011 % which means that it generated a profit of $0.011 on every $100 spent on assets. This is way below average. Yew Bio's management efficiency ratios could be used to measure how well Yew Bio manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 9.32 M in liabilities with Debt to Equity (D/E) ratio of 0.2, which may suggest the company is not taking enough advantage from borrowing. Yew Bio Pharm has a current ratio of 1.09, suggesting that it may not have the ability to pay its financial obligations when due. Debt can assist Yew Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Yew Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Yew Bio Pharm sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Yew to invest in growth at high rates of return. When we think about Yew Bio's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 10 records | CHAIRMAN Age | ||
| David Netherway | Academy Sports OutdoorsInc | N/A | |
| Alan Thomson | Hasbro Inc | 70 | |
| Michelangelo Volpi | Sonos Inc | 51 | |
| Andrew Martin | Hasbro Inc | 57 | |
| John Kim | Amkor Technology | 48 | |
| Peter Cowgill | JD Sports Fashion | 64 | |
| Brian Goldner | Hasbro Inc | 54 | |
| Susan Kim | Amkor Technology | 61 | |
| James Kim | Amkor Technology | 88 | |
| Kenneth Hicks | Academy Sports OutdoorsInc | 72 | |
Management Performance
| Return On Equity | 0.0085 | |||
| Return On Asset | 0.011 |
Yew Bio Pharm Leadership Team
Elected by the shareholders, the Yew Bio's board of directors comprises two types of representatives: Yew Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Yew. The board's role is to monitor Yew Bio's management team and ensure that shareholders' interests are well served. Yew Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Yew Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Xingming Han, General Manager of Harbin Yew Science and Technology Devel. Co Ltd | ||
| Nan Tian, CFO, Director | ||
| Tao Hui, Independent Director | ||
| Yuxi Xing, CFO | ||
| Liu Xiefeng, Independent Director | ||
| Yongchun Shi, Independent Director | ||
| Guifang Qi, Treasurer and Director | ||
| Guoshuang Tian, Independent Director | ||
| Madam Qi, CFO, CEO | ||
| Zhiguo Wang, Founder, Chairman, CEO and President CFO and Secretary | ||
| Liu Chang, Independent Director |
Yew Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Yew Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0085 | |||
| Return On Asset | 0.011 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 9.23 M | |||
| Shares Outstanding | 59.19 M | |||
| Shares Owned By Insiders | 43.99 % | |||
| Price To Book | 0.0001 X | |||
| Price To Sales | 0.0002 X | |||
| Revenue | 27.31 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Yew Pink Sheet
If you are still planning to invest in Yew Bio Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Yew Bio's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |